Global medical device company Medtronic has been very active in 2019 with acquisitions, device launches and clinical studies. Here is a timeline of 10 of the company's major events so far this year.
January 24: Signs an agreement to acquire cardiac ablation system manufacturer EPIX Therapeutics.
January 28: Four months after the acquisition of Mazor, Medtronic launches the Mazor X Stealth Edition for spine surgery.
January 15: Launches the app MyCareLink Heart, enabling patients to access data from their pacemakers on their smartphones.
January 17: Enrolls its first patient in a clinical study to assess pain control and oral opioid elimination with targeted drug delivery.
February 18: It is revealed the company is closing its facility in Portsmouth, N.H., affecting approximately 150 jobs as part of a restructuring plan.
February 19: Reports financial results for its third quarter of fiscal year 2019. Third quarter worldwide revenue of $7.546 billion — a rise of 4.4 percent on an organic basis.
April 15: University of California San Diego is reported as the state's first healthcare system to adapt Medtronic's Mazor X Stealth Edition System.
May 9: Health technology firm Royal Philips collaborates with Medtronic to advance treatment of paroxysmal atrial fibrillation, a common heart rhythm disorder.
May 9: Medtronic enters into a definitive agreement to acquire titanium spine interbody implant and surface technology company, Titan Spine.
May 14: It is reported that Muskegon (Mich.) Surgery Center became the state's first ASC to use Medtronic's Mazor X Stealth Edition robot guidance system for spine surgery.